VACC
$5
Revenue | $0.33Mn |
Net Profits | $-23.8Mn |
Net Profit Margins | -7126.35% |
Vaccitech plc’s revenue fell -98.04% since last year same period to $0.33Mn in the Q2 2023. On a quarterly growth basis, Vaccitech plc has generated -28.63% fall in its revenue since last 3-months.
Vaccitech plc’s net profit fell -251.67% since last year same period to $-23.8Mn in the Q2 2023. On a quarterly growth basis, Vaccitech plc has generated -30.62% fall in its net profits since last 3-months.
Vaccitech plc’s net profit margin fell -7848.48% since last year same period to -7126.35% in the Q2 2023. On a quarterly growth basis, Vaccitech plc has generated -83.02% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.5 |
EPS Estimate Current Year | -0.5 |
Vaccitech plc’s earning per share (EPS) estimates for the current quarter stand at -0.5 - a 5.04% jump from last quarter’s estimates.
Vaccitech plc’s earning per share (EPS) estimates for the current year stand at -0.5.
Earning Per Share (EPS) | 0 |
Vaccitech plc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2023. This indicates that the Vaccitech plc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-13 | -0.53 | 0 | 100% |
2023-08-10 | -0.55 | -0.62 | -12.73% |
2023-05-12 | -0.5 | -0.48 | 4% |
2024-03-22 | -0.5 | 0 | 100% |